Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
7.55
+3.27 (76.40%)
At close: Oct 1, 2026, 4:00 PM EDT
6.00
-1.55 (-20.53%)
Pre-market: Oct 2, 2026, 8:37 AM EDT
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $5.55 million as of October 1, 2026. Its market cap has decreased by -65.29% in one year.
Market Cap
5.55M
Enterprise Value
4.54M
1-Year Change
-65.29%
Ranking
Category
Stock Price
$7.55
ChartMarket Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has decreased from $16.38M to $5.55M, a decrease of -66.14%. That is a compound annual growth rate of -23.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 5.55M | -46.71% |
| Dec 31, 2025 | 10.41M | -70.68% |
| Dec 31, 2024 | 35.50M | 1,079.21% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
| Sep 16, 2022 | 16.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IceCure Medical | 7.91M |
| Co-Diagnostics | 6.75M |
| Phaos Technology Holdings (Cayman) Limited | 5.62M |
| enVVeno Medical | 5.49M |
| 20/20 Biolabs | 5.22M |
| Trinity Biotech | 5.14M |
| Intelligent Bio Solutions | 5.03M |
| Aethlon Medical | 4.71M |